Loss of endothelial cell-specific autophagy-related protein 7 exacerbates doxorubicin-induced cardiotoxicity
Doxorubicin (DOX) is an effective, broad-spectrum antineoplastic agent with serious cardiotoxic side effects, which may lead to the development of heart failure. Current strategies to diagnose, prevent, and treat DOX-induced cardiotoxicity (DIC) are inadequate. Recent evidence has linked the dysregu...
Main Authors: | Albert Z. Luu, Vincent Z. Luu, Biswajit Chowdhury, Andrew Kosmopoulos, Yi Pan, Mohammed Al-Omran, Adrian Quan, Hwee Teoh, David A. Hess, Subodh Verma |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-03-01
|
Series: | Biochemistry and Biophysics Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405580821000200 |
Similar Items
-
Luteolin Attenuates Doxorubicin-Induced Cardiotoxicity Through Promoting Mitochondrial Autophagy
by: Haixia Xu, et al.
Published: (2020-02-01) -
Cardiotoxicity of doxorubicin – causes, prevention, prospects
by: Paweł Wesołowski, et al.
Published: (2022-11-01) -
Doxorubicin downregulates autophagy to promote apoptosis-induced dilated cardiomyopathy via regulating the AMPK/mTOR pathway
by: Sheng Zhang, et al.
Published: (2023-06-01) -
Targeting Oxidative Stress, NLRP3 Inflammasome, and Autophagy by Fraxetin to Combat Doxorubicin-Induced Cardiotoxicity
by: Ahmed M. Kabel, et al.
Published: (2021-11-01) -
The role of endothelin-1 in the doxorubicin cardiotoxicity
by: Lilia Tacu
Published: (2020-10-01)